{
    "organizations": [],
    "uuid": "c69efa5845345446d5cac387fc2ae0c214583102",
    "author": "",
    "url": "https://www.reuters.com/article/brief-crescita-therapeutics-q4-net-loss/brief-crescita-therapeutics-q4-net-loss-per-share-0-59-idUSASC09TXX",
    "ord_in_thread": 0,
    "title": "BRIEF-Crescita Therapeutics Q4 Net Loss Per Share $0.59",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 45 AM / in 9 minutes BRIEF-Crescita Therapeutics Q4 Net Loss Per Share $0.59 Reuters Staff \nMarch 28 (Reuters) - Crescita Therapeutics Inc: \n* CRESCITA THERAPEUTICS REPORTS 2017 FOURTH QUARTER AND YEAR END RESULTS \n* QTRLY NET LOSS PER SHARE FROM CONTINUING OPERATIONS $0.59 * QTRLY REVENUE C$2.4 MILLION VERSUS C$2.2 MILLION \n* CASH AND CASH EQUIVALENTS WERE $7.0 MILLION AS AT DECEMBER 31, 2017 COMPARED TO $9.8 MILLION AS AT DECEMBER 31, 2016 Source text for Eikon: Further company coverage:",
    "published": "2018-03-28T14:42:00.000+03:00",
    "crawled": "2018-03-28T15:06:43.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "minute",
        "therapeutic",
        "q4",
        "net",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "march",
        "reuters",
        "crescita",
        "therapeutic",
        "inc",
        "crescita",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "year",
        "end",
        "result",
        "qtrly",
        "net",
        "loss",
        "per",
        "share",
        "continuing",
        "operation",
        "qtrly",
        "revenue",
        "c",
        "million",
        "versus",
        "c",
        "million",
        "cash",
        "cash",
        "equivalent",
        "million",
        "december",
        "compared",
        "million",
        "december",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}